For targeted joint or muscle repair, subcutaneous BPC-157 injections are often the most effective route
Summary: Retatrutide and tesamorelin are both peptide-based compounds used in metabolic medicine, but retatrutide is an unapproved triple incretin receptor agonist in clinical trials, while tesamorelin is a GHRH analogue licensed in the US for HIV-associated lipodystrophy but unlicensed in the UK
Just watch artificial sweeteners some bariatric patients report GI distress with large amounts of sugar alcohols
What I'd push back on is defaulting to Ozempic simply because it's the most famous
From a functional medicine standpoint: Topical copper peptides are ideal for localized, consistent, preventative skin longevity Injectable copper peptides are reserved for select patients seeking more aggressive or systemic regenerative support For this reason, many patients begin with topical copper peptides and only consider injectable options when clinically appropriate
This article explains the main ways that Ozempic and Mounjaro are alike and different